Wall Street Reporter Exclusive Interviews with CEO's of: MDCL, HEXO, ELLXF, SOLO
Wednesday, 20 February 2019 *NEW YORK, NY / ACCESSWIRE / February 20, 2019 / *Wall Street Reporter, the leading name in financial news since 1843, has recently published interviews with CEO's of some of today's most talked about, trending stocks. These interviews are available in audio and video on www.WallStreetReporter.com
*Medicine Man Technologies (MDCL) CEO Interview with Andy Williams*, *co-founder, and CEO.*
Andy provides an update on the company's transformation into a vertically integrated cannabis operator, through recently announced acquisitions, which will put MDCL on track to $40-50 million+ revenue run rate, and healthy profits in 2019.
Medicine Man Technologies current business provides turn-key solutions for the cannabis industry, helping growers and retailers manage and optimize their revenues. This business grew 157% year-over-year, in 2018 to $9 million revenues and $2.3 million net income.
The newly announced acquisitions announced include:
Medicine Man Denver - an award-winning cannabis grower and multi-location marijuana retailer in the Denver area, with revenues in the $25 million range (and profits) expected in 2019.
MedPharm Holdings - a phytopharmaceutical and intellectual property holding company developing innovative cannabis products, using accepted pharmaceutical formulation techniques, to reliably produce identifiable and replicable dosage forms for human use. MedPharm is revenue positive and expected to be profitable in 2019.
In this exclusive interview with Wall Street Reporter, Andy discusses the company's profitable business model, operations, and how the newly announced acquisitions will be transformative for MDCL's growth.
(Notably, MDCL is one of the few publicly-traded companies in the cannabis space, that is actually profitable today.)
FREE public access to the complete 19 minute CEO interview (VIDEO) is available at:
*Elixinol Global Limited (ELLXF) CEO Interview with Paul Benhaim.*
Paul discusses Elixinol's progress in the CBD and hemp consumer products and foods markets, which has resulted in over AUD$14 million revenues and profits in Q2 2018.
The complete 19 minute CEO interview (VIDEO) is available at: https://www.wallstreetreporter.com/2018/12/elixinol-global-limited-otc-ellxf-fast-growing-revenues-in-cbd-hemp-consumer-products/
WALL STREET REPORTER
590 Madison Avenue
New York, NY 10022
(212) 871-2057 ext 7
Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO's of promising, publicly-traded companies, and market experts.
Wall Street Reporter's global investor audience consists primarily of hedge fund managers, investment advisors, analysts, investment bankers, and self-directed individual investors managing over $2 trillion in capital worldwide.
DISCLAIMER: MDCL and ELLXF have sponsored free public access to their CEO interview, which was originally posted in members-only and available for paid subscribers only. Editorial policy: Our interviews are produced as editorial content available for access to paid subscribers. Post-interview, companies have the option of sponsoring their interview, to enable free public access.Rule17b updated disclosures available at https://www.wallstreetreporter.com/legal-notice/
*SOURCE:* Wall Street Reporter
View source version on accesswire.com: